Avista Healthcare Partners

Avista Healthcare Partners is a private equity firm based in New York, founded in 2005, that specializes in investing in mid-sized companies within the healthcare sector. The firm focuses on various areas, including pharmaceuticals, medical devices, outsourced pharmaceutical services, distribution, and consumer-driven healthcare. Avista aims to support the growth and development of these companies, contributing to advancements in healthcare technology and services.

David Burgstahler

Managing Partner and Co-CEO

Thompson Dean

Managing Partner and Co-CEO

24 past transactions

Trillium Health Care Products

Acquisition in 2024
Trillium Health Care Products Inc. is a contract manufacturer specializing in the production of prescription and over-the-counter life science products for the pharmaceutical and consumer sectors in North America. Established in 1993 and headquartered in Brockville, Canada, the company provides a diverse range of products, including gastrointestinal remedies, cough, cold and flu medications, antiseptic ointments, suppositories, nasal sprays, allergy relief, analgesics, and sleep aids. Additionally, Trillium produces cosmetic products in various forms, including solids, semi-solids, and liquids. The company emphasizes sound environmental, health, and safety management practices, ensuring quality and compliance for its partners across the healthcare sector.

Terrats Medical

Acquisition in 2024
Terrats Medical is a manufacturer specializing in dental implants and prostheses, catering to the medical industry. The company produces a range of products, including dental implants and abutments-related items, alongside various medical devices. In addition to manufacturing, Terrats Medical offers engineering, production, and certification services, ensuring that clients have access to dependable facilities for abutment production. Through its comprehensive offerings, the company aims to support dental professionals with high-quality solutions.

Spear Education

Acquisition in 2022
Spear Education is a provider of education and training services aimed at enhancing the skills of dental professionals. The company offers a range of learning opportunities, including hands-on courses, peer-to-peer regional learning, and comprehensive online educational tools. These programs focus on real-life cases and the latest treatment techniques, fostering an environment of guided learning and interaction among small groups of like-minded peers. By equipping dentists with higher acuity skills and enabling them to generate new revenue streams, Spear Education supports healthcare professionals in improving their knowledge base and achieving a higher return on investment.

Taconic Biosciences

Acquisition in 2022
Taconic Biosciences, Inc. is a leading provider of custom model generation and breeding services, specializing in genetically engineered and cryopreserved live mice and rats for research purposes. Founded in 1952 and headquartered in Hudson, New York, the company operates several breeding facilities across the United States and Europe. Taconic serves a diverse range of sectors including pharmaceuticals, biotechnology, and academic institutions, offering services such as model design, breeding, phenotyping, and surgical modifications. The company's focus is on enhancing research in areas such as oncology, neuroscience, immunology, and metabolic disorders, while maintaining a commitment to ethical animal use and care. By providing high-quality and relevant research models, Taconic aims to facilitate significant advancements in human health and reduce the number of animals needed for scientific inquiry. The company has established a strategic partnership with Cyagen Biosciences to further enhance its service offerings.

WellSpring Pharmaceutical

Acquisition in 2022
WellSpring Pharmaceutical Corporation, founded in 1999 by Dr. Robert Vukovich, is a privately held company based in Sarasota, Florida, with a manufacturing facility in Ontario, Canada. The company specializes in the manufacture, marketing, and distribution of both prescription and over-the-counter medications. Its product portfolio includes well-known brands such as Emetrol, Micatin, Gelusil, and Glaxal Base Skin Cream and Lotion. WellSpring offers a range of healthcare solutions including heartburn relief, motion sickness remedies, antifungal treatments for athlete's foot and jock itch, infection protection, and skin moisturizers. Additionally, the company provides pharmaceutical contract manufacturing services to clients in North America and Europe, serving consumers, healthcare professionals, and retailers alike.

Probo Medical

Acquisition in 2022
Probo Medical is a diversified supplier of refurbished medical equipment, specializing in medical imaging technologies such as ultrasound, C-arms, CT, MRI, PET/CT, and X-ray systems. The company provides a comprehensive range of services, including equipment refurbishment, sales, parts supply, and repair services. Additionally, Probo Medical offers equipment rentals and both depot and field-based repair services, aiming to make medical imaging solutions more accessible and affordable for healthcare practices. By integrating various products and services, Probo Medical helps clients reduce healthcare costs and make informed decisions about their imaging needs.

Solmetex

Acquisition in 2020
Solmetex, Inc. is a manufacturer based in Northborough, Massachusetts, specializing in amalgam separators for the dental industry in the United States and Canada. Founded in 1994, the company provides a variety of products aimed at water treatment and waste management for dental practices. Its offerings include collection containers, disposal kits suitable for various practice sizes, and approved storage and shipping containers. Notably, the Hg5 Plus system is a specialized solution designed to reduce amalgam waste and dissolved mercury. Solmetex distributes its products through a dealer network across North America, ensuring that dental offices can operate safely and in compliance with environmental regulations.

Vision Healthcare

Acquisition in 2020
Vision Healthcare is an independent entity in the consumer healthcare sector, featuring a diverse portfolio of self-care and over-the-counter (OTC) brands across several European countries. The company emphasizes an omnichannel marketing strategy, leveraging both traditional and digital platforms, particularly in direct-to-consumer channels. Its product offerings include vitamins, nutritional supplements, cosmetics, personal care items, and OTC medicines. Vision Healthcare is committed to a buy-and-build strategy, acting as a consolidator in the European market and beyond, which enables its group companies to utilize a shared backend platform for efficient and sustainable growth.

GCM Global

Acquisition in 2019
For nearly 40 years, GCM has been on a journey grounded by unwavering organizational principles. Everyone at GCM strives to conduct him or herself in a highly professional manner by following three core values. They believe that when their values are acted upon in unison, they foster the ultimate customer experiences.

G&W Laboratories

Acquisition in 2018
G&W Laboratories, Inc. is a pharmaceutical company based in South Plainfield, New Jersey, founded in 1918. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including generics and over-the-counter medications. Their product offerings encompass analgesics, antifungals, anti-inflammatories, antibiotics, antiemetics, and stimulant laxatives, available in various forms such as creams, ointments, gels, and suppositories. In addition to its proprietary product line, G&W Laboratories provides contract manufacturing services, which include formulation development, analytical method research and validation, pilot and scale-up batch production, and process validation. The company distributes its products through retailers, distributors, and wholesalers, and exports to multiple countries worldwide.

Braeburn

Debt Financing in 2018
Braeburn Inc. is a pharmaceutical company focused on developing and commercializing treatments for serious central nervous system disorders, with a primary emphasis on opioid addiction. Founded in 2012 and headquartered in Plymouth Meeting, Pennsylvania, Braeburn aims to provide innovative solutions for individuals affected by opioid use disorder (OUD). The company's lead product candidate, BRIXADI, is an extended-release injectable formulation of buprenorphine designed for the treatment of moderate to severe OUD. Braeburn is committed to advancing next-generation therapies that offer individualized dosing regimens and delivery options, striving to improve care for patients and address the growing challenges associated with addiction.

United Biosource Corporation

Acquisition in 2017
United Biosource Corporation (UBC) is a prominent provider of pharmaceutical support services that collaborates with life science companies to enhance the safety and accessibility of medicines and medical products. UBC offers a comprehensive range of services designed to connect the development of pharmaceutical products with their delivery to patients. The company focuses on improving patient access to medications and fostering adherence to treatment regimens, ultimately aiming to build brand loyalty among healthcare providers and patients. As part of its commitment to the life sciences sector, UBC plays a critical role in ensuring that innovative therapies reach the market and are effectively utilized by those who need them.

Miraca Life Sciences

Acquisition in 2017
Miraca Life Sciences provides the highest quality anatomic pathology services, primarily in the fields of gastroenterology, dermatology, hematology, breast health, and urology. The company's team of more than 90 distinguished expert subspecialists utilizes state-of-the-art pathology laboratories to serve more than 5,500 patients every day. Miraca Life Sciences continuously improves diagnostic accuracy through consensus-based terminology and criteria, rigorous quality assurance, daily consensus conferences, extensive educational and training activities and close relationships with clinical partners.

National Spine & Pain Centers

Acquisition in 2017
National Spine & Pain Centers (NSPC) is a prominent operator of interventional pain management clinics headquartered in Frederick, Maryland. With over 120 locations and a network of 750 medical professionals, NSPC serves nearly a million patients annually, focusing on the relief of chronic and acute pain through minimally invasive procedures. The affiliated physicians are highly qualified, often holding double or triple board certifications, and are recognized as leaders in the field of pain management. Additionally, NSPC is committed to advancing pain-related research, with its physicians having authored numerous publications in peer-reviewed medical journals. The organization not only provides administrative support to pain management clinics but also offers management services to physicians in ambulatory surgical centers, ensuring comprehensive care for patients suffering from chronic back and neck pain.

OptiNose

Series D in 2017
OptiNose is a specialty pharmaceutical company dedicated to developing and commercializing nasal drug delivery technologies and combination drug/device therapies. The company’s proprietary Bi-Directional Delivery system enhances the efficiency of drug administration to the nasal cavity, ensuring that a significant portion of the medication is deposited in the upper posterior regions, rather than the lungs. This innovative approach has been shown to provide a faster onset of action, greater therapeutic effects with lower doses, and reduced side effects in clinical trials. One of its key products, XHANCE, is a nasal spray containing fluticasone propionate, specifically designed to treat chronic rhinosinusitis with nasal polyps by delivering medication directly to the site of inflammation. OptiNose operates offices in Norway and the UK, focusing on patients supported by ear, nose, and throat specialists, as well as allergy professionals.

OptiNose

Series C in 2015
OptiNose is a specialty pharmaceutical company dedicated to developing and commercializing nasal drug delivery technologies and combination drug/device therapies. The company’s proprietary Bi-Directional Delivery system enhances the efficiency of drug administration to the nasal cavity, ensuring that a significant portion of the medication is deposited in the upper posterior regions, rather than the lungs. This innovative approach has been shown to provide a faster onset of action, greater therapeutic effects with lower doses, and reduced side effects in clinical trials. One of its key products, XHANCE, is a nasal spray containing fluticasone propionate, specifically designed to treat chronic rhinosinusitis with nasal polyps by delivering medication directly to the site of inflammation. OptiNose operates offices in Norway and the UK, focusing on patients supported by ear, nose, and throat specialists, as well as allergy professionals.

OptiNose

Series C in 2014
OptiNose is a specialty pharmaceutical company dedicated to developing and commercializing nasal drug delivery technologies and combination drug/device therapies. The company’s proprietary Bi-Directional Delivery system enhances the efficiency of drug administration to the nasal cavity, ensuring that a significant portion of the medication is deposited in the upper posterior regions, rather than the lungs. This innovative approach has been shown to provide a faster onset of action, greater therapeutic effects with lower doses, and reduced side effects in clinical trials. One of its key products, XHANCE, is a nasal spray containing fluticasone propionate, specifically designed to treat chronic rhinosinusitis with nasal polyps by delivering medication directly to the site of inflammation. OptiNose operates offices in Norway and the UK, focusing on patients supported by ear, nose, and throat specialists, as well as allergy professionals.

Laredo Energy

Private Equity Round in 2014
Laredo Energy, LLC is a privately held company focused on the acquisition, exploration, and development of natural gas and oil reserves primarily in South Texas and East Central Texas. Established in 2001 and headquartered in Houston, Texas, with a field office in Laredo, the company has successfully drilled over 200 operated wells in Webb and Zapata counties and continues to drill 20 to 30 operated wells annually. Laredo Energy exports and sells its natural gas to various end markets both domestically and internationally. The company is backed by equity capital from Avista Capital Partners and Liberty Energy Holdings, which is managed by Old Ironsides Energy.

Rottapharm

Acquisition in 2012
Rottapharm, founded in 1961, has established itself as a prominent player in the pharmaceutical industry, initially starting as a small research laboratory. The company focuses on research, innovation, and the global development and distribution of pharmaceutical products. Over the years, Rottapharm has expanded its offerings to include parapharmaceuticals and nutraceuticals, conducting research and development across various therapeutic areas, including gastroenterology, psychiatry, and oncology. Following its acquisition of the German company Madaus Pharma, Rottapharm has solidified its position as one of Italy's leading pharmaceutical firms, with a presence in over 85 countries. In addition to pharmaceuticals, Rottapharm's product portfolio encompasses personal care items, medical devices, and dermatological products.

Anthony

Acquisition in 2011
Anthony, based in Sylmar, California, is a manufacturer and solutions provider specializing in glass refrigerator and freezer doors, along with associated products such as lighting systems and display equipment for commercial refrigeration systems. The company focuses on enhancing merchandising, ensuring food safety, and protecting the environment through its innovative designs. With over 50 years of experience, Anthony has established itself as a preferred supplier in the refrigeration industry by committing to quality, customer service, and continuous improvement. Their diverse product offerings also include beer cave doors, shelving, viewing windows, sliding doors, and various accessories, catering to a global market. Anthony is part of the Refrigeration and Food Equipment segment of Dover Corporation.

DataBank

Acquisition in 2011
DataBank Holdings, Ltd. is a data center and co-location company headquartered in Dallas, Texas, with additional facilities in the Dallas/Fort Worth area, Minneapolis/St. Paul, Eagan, Kansas City, and Atlanta. Founded in 2004, DataBank provides a comprehensive array of services, including co-location solutions that ensure security, power configurations, and cooling. The company also offers managed services such as cloud computing, virtual hosting, network connectivity, and security, along with consulting services that encompass design and implementation, migration, and continuity planning. DataBank emphasizes compliance with various industry standards, including those for payment card security and health data protection. Catering to a diverse clientele across sectors like healthcare, finance, gaming, and hospitality, DataBank is committed to optimizing IT environments and ensuring data availability for enterprises.

OptiNose

Private Equity Round in 2010
OptiNose is a specialty pharmaceutical company dedicated to developing and commercializing nasal drug delivery technologies and combination drug/device therapies. The company’s proprietary Bi-Directional Delivery system enhances the efficiency of drug administration to the nasal cavity, ensuring that a significant portion of the medication is deposited in the upper posterior regions, rather than the lungs. This innovative approach has been shown to provide a faster onset of action, greater therapeutic effects with lower doses, and reduced side effects in clinical trials. One of its key products, XHANCE, is a nasal spray containing fluticasone propionate, specifically designed to treat chronic rhinosinusitis with nasal polyps by delivering medication directly to the site of inflammation. OptiNose operates offices in Norway and the UK, focusing on patients supported by ear, nose, and throat specialists, as well as allergy professionals.

Thompson publishing group

Acquisition in 2006
Thompson Publishing Group is an information service provider specializing in compliance resources, training, online databases, and customized data delivery. They offer a wide range of services including compliance information, training programs, and detailed data in various subject areas such as federal grants, government contracting, FDA regulations, energy policies, and financial services. With a focus on delivering comprehensive and up-to-date information, Thompson Publishing Group serves businesses and professionals seeking reliable resources for staying compliant and informed in their respective industries.

WideOpenWest

Acquisition in 2005
WideOpenWest, Inc. is a telecommunications company based in Englewood, Colorado, that offers high-speed internet, cable television, and digital telephony services to both residential and business customers across the United States. The company's video offerings include basic and digital cable services, ultra-video products, and various entertainment options such as movies and sports programming. In addition to video services, WideOpenWest provides a range of telephony solutions, including local and long-distance telephone services, fiber-based business telephony, and data services such as cloud computing and managed backup. Established in 2001, the company serves approximately 3.2 million customers in states including Alabama, Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Ohio, South Carolina, and Tennessee. WideOpenWest was formerly known as WideOpenWest Kite, Inc. and rebranded in March 2017.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.